CRISIL Limited (CRISIL) Fair Value & Analysis
Financial Services · IN · Market cap ₹299B
Fair value as of: Jun 29, 2026
Analysis
CRISIL Limited (CRISIL) currently trades at ₹4,090, while our model-based Fair Value estimate is ₹1,362 — implying the stock looks roughly 66.7% overvalued today. We read business quality at 95/100 (high quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
CRISIL Limited, an analytical company, provides ratings, research, and risk and policy consulting services in India, Europe, North America, and internationally. It operates through two segment, Rating Services; and Research, Analytics and Solutions. The company offers credit ratings for corporates, banks, and bank loans; credit analysis services; grading services; and analytical services. It also provides research and risk solutions, industry reports, customized research assignments, subscription to data services, training, and advisory services; and a range of risk management tools, analytics, and solutions for financial institutions, banks, and corporates. The company was formerly known as The Credit Rating Information Services of India Limited and changed its name to CRISIL Limited in December 2003. CRISIL Limited was incorporated in 1987 and is headquartered in Mumbai, India.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is CRISIL Limited (CRISIL) undervalued?
What is the fair value of CRISIL?
What is the quality score of CRISIL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.